| Year |
Citation |
Score |
| 2019 |
Hume JR, Zhang Y, Zhang L, Peterson M, Carlson DL. Cardiac gene expression and function in a mouse model of community-acquired methicillin-resistant Staphylococcus aureus sepsis: Role of inflammatory caspases 1 and 11 European Journal of Inflammation. 17: 205873921983838. DOI: 10.1177/2058739219838389 |
0.368 |
|
| 2018 |
Anderson MJ, Schaaf E, Breshears LM, Wallis HW, Johnson JR, Tkaczyk C, Sellman BR, Sun J, Peterson ML. Alpha-Toxin Contributes to Biofilm Formation among Staphylococcus aureus Wound Isolates. Toxins. 10. PMID 29659477 DOI: 10.3390/Toxins10040157 |
0.433 |
|
| 2018 |
Hashemi MM, Rovig J, Holden BS, Taylor MF, Weber S, Wilson J, Hilton B, Zaugg AL, Ellis SW, Yost CD, Finnegan PM, Kistler CK, Berkow EL, Deng S, Lockhart SR, ... Peterson M, et al. Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms. The Journal of Antimicrobial Chemotherapy. PMID 29635279 DOI: 10.1093/Jac/Dky085 |
0.324 |
|
| 2018 |
Peterson M, Kilgore S, Schlievert P. 1362. A Novel Intravesical Antimicrobial for CAUTIs Open Forum Infectious Diseases. 5: S417-S417. DOI: 10.1093/Ofid/Ofy210.1193 |
0.351 |
|
| 2017 |
Gillman AN, Breshears LM, Kistler CK, Finnegan PM, Torres VJ, Schlievert PM, Peterson ML. Epidermal Growth Factor Receptor Signaling Enhances the Proinflammatory Effects of Staphylococcus aureus Gamma-Toxin on the Mucosa. Toxins. 9. PMID 28657583 DOI: 10.3390/Toxins9070202 |
0.442 |
|
| 2016 |
Breshears LM, Gillman AN, Stach CS, Schlievert PM, Peterson ML. Local Epidermal Growth Factor Receptor Signaling Mediates the Systemic Pathogenic Effects of Staphylococcus aureus Toxic Shock Syndrome. Plos One. 11: e0158969. PMID 27414801 DOI: 10.1371/Journal.Pone.0158969 |
0.355 |
|
| 2016 |
Peterson ML. A long road to a preventative for toxic shock syndrome. The Lancet. Infectious Diseases. PMID 27296692 DOI: 10.1016/S1473-3099(16)30163-3 |
0.318 |
|
| 2016 |
Richmond GE, Evans LP, Anderson MJ, Wand ME, Bonney LC, Ivens A, Chua KL, Webber MA, Sutton JM, Peterson ML, Piddock LJ. The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner. Mbio. 7. PMID 27094331 DOI: 10.1128/Mbio.00430-16 |
0.395 |
|
| 2016 |
Breshears LM, Peterson ML. Protocol for Examining Human Vaginal Epithelial Cell Signaling in Response to Staphylococcal Superantigens. Methods in Molecular Biology (Clifton, N.J.). 1396: 149-58. PMID 26676045 DOI: 10.1007/978-1-4939-3344-0_13 |
0.318 |
|
| 2016 |
Peterson M, Anderson M, Breshears L, Nordby T, Stevens MH, Scholz M. Efficacy of Skin and Nasal Povidone-Iodine Preparation and Iodine-Containing Formulations in Treating Methicillin-Resistant Staphylococcus aureus Colonization of Ex Vivo Mucosal Tissue Model Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.150 |
0.358 |
|
| 2015 |
Breshears LM, Edwards VL, Ravel J, Peterson ML. Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model. Bmc Microbiology. 15: 276. PMID 26652855 DOI: 10.1186/S12866-015-0608-0 |
0.388 |
|
| 2015 |
Haase AT, Rakasz E, Schultz-Darken N, Nephew K, Weisgrau KL, Reilly CS, Li Q, Southern PJ, Rothenberger M, Peterson ML, Schlievert PM. Glycerol Monolaurate Microbicide Protection against Repeat High-Dose SIV Vaginal Challenge. Plos One. 10: e0129465. PMID 26057743 DOI: 10.1371/Journal.Pone.0129465 |
0.337 |
|
| 2015 |
Anderson MJ, David ML, Scholz M, Bull SJ, Morse D, Hulse-Stevens M, Peterson ML. Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares. Antimicrobial Agents and Chemotherapy. 59: 2765-73. PMID 25733504 DOI: 10.1128/Aac.04624-14 |
0.377 |
|
| 2015 |
Breshears L, Edwards V, Ravel J, Peterson M. P06.09 Lactobacillus crispatus inhibits growth of gardnerella vaginalis and neisseria gonorrhoeae on a porcine vaginal mucosa model Sexually Transmitted Infections. 91. DOI: 10.1136/Sextrans-2015-052270.310 |
0.363 |
|
| 2014 |
Muthyala R, Rastogi N, Shin WS, Peterson ML, Sham YY. Cell permeable vanX inhibitors as vancomycin re-sensitizing agents Bioorganic and Medicinal Chemistry Letters. 24: 2535-2538. PMID 24751446 DOI: 10.1016/J.Bmcl.2014.03.097 |
0.317 |
|
| 2014 |
Spaulding AR, Salgado-Pabón W, Merriman JA, Stach CS, Ji Y, Gillman AN, Peterson ML, Schlievert PM. Vaccination against Staphylococcus aureus pneumonia. The Journal of Infectious Diseases. 209: 1955-62. PMID 24357631 DOI: 10.1093/Infdis/Jit823 |
0.392 |
|
| 2013 |
Salgado-Pabón W, Breshears L, Spaulding AR, Merriman JA, Stach CS, Horswill AR, Peterson ML, Schlievert PM. Superantigens are critical for Staphylococcus aureus Infective endocarditis, sepsis, and acute kidney injury. Mbio. 4. PMID 23963178 DOI: 10.1128/Mbio.00494-13 |
0.417 |
|
| 2013 |
Anderson MJ, Scholz MT, Parks PJ, Peterson ML. Ex vivo porcine vaginal mucosal model of infection for determining effectiveness and toxicity of antiseptics. Journal of Applied Microbiology. 115: 679-88. PMID 23773892 DOI: 10.1111/Jam.12277 |
0.351 |
|
| 2013 |
Anderson MJ, Parks PJ, Peterson ML. A mucosal model to study microbial biofilm development and anti-biofilm therapeutics. Journal of Microbiological Methods. 92: 201-8. PMID 23246911 DOI: 10.1016/J.Mimet.2012.12.003 |
0.389 |
|
| 2012 |
Anderson MJ, Lin YC, Gillman AN, Parks PJ, Schlievert PM, Peterson ML. Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation. Frontiers in Cellular and Infection Microbiology. 2: 64. PMID 22919655 DOI: 10.3389/Fcimb.2012.00064 |
0.639 |
|
| 2012 |
Spaulding AR, Satterwhite EA, Lin YC, Chuang-Smith ON, Frank KL, Merriman JA, Schaefers MM, Yarwood JM, Peterson ML, Schlievert PM. Comparison of Staphylococcus aureus strains for ability to cause infective endocarditis and lethal sepsis in rabbits. Frontiers in Cellular and Infection Microbiology. 2: 18. PMID 22919610 DOI: 10.3389/Fcimb.2012.00018 |
0.736 |
|
| 2012 |
Breshears LM, Schlievert PM, Peterson ML. A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1). The Journal of Biological Chemistry. 287: 32578-87. PMID 22833676 DOI: 10.1074/Jbc.M112.352534 |
0.375 |
|
| 2012 |
Schlievert PM, Peterson ML. Glycerol monolaurate antibacterial activity in broth and biofilm cultures. Plos One. 7: e40350. PMID 22808139 DOI: 10.1371/Journal.Pone.0040350 |
0.413 |
|
| 2012 |
Spaulding AR, Lin YC, Merriman JA, Brosnahan AJ, Peterson ML, Schlievert PM. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses. Vaccine. 30: 5099-109. PMID 22691432 DOI: 10.1016/J.Vaccine.2012.05.067 |
0.629 |
|
| 2012 |
Schaefers MM, Breshears LM, Anderson MJ, Lin YC, Grill AE, Panyam J, Southern PJ, Schlievert PM, Peterson ML. Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1. Plos One. 7: e32813. PMID 22431984 DOI: 10.1371/Journal.Pone.0032813 |
0.735 |
|
| 2011 |
Lin YC, Anderson MJ, Kohler PL, Strandberg KL, Olson ME, Horswill AR, Schlievert PM, Peterson ML. Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus. Biochemistry. 50: 7157-67. PMID 21749039 DOI: 10.1021/Bi200435N |
0.657 |
|
| 2011 |
Parks P, Anderson M, Peterson M. An active dressing prevents formation of Staphylococcus aureus biofilm on a mucosal surface Bmc Proceedings. 5: 62. DOI: 10.1186/1753-6561-5-S6-P62 |
0.401 |
|
| 2010 |
Lin YC, Peterson ML. New insights into the prevention of staphylococcal infections and toxic shock syndrome. Expert Review of Clinical Pharmacology. 3: 753-767. PMID 21625323 DOI: 10.1586/Ecp.10.121 |
0.645 |
|
| 2010 |
Anderson MJ, Horn ME, Lin YC, Parks PJ, Peterson ML. Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens. American Journal of Infection Control. 38: 826-31. PMID 21035920 DOI: 10.1016/J.Ajic.2010.06.022 |
0.526 |
|
| 2010 |
Schlievert PM, Chuang-Smith ON, Peterson ML, Cook LC, Dunny GM. Enterococcus faecalis endocarditis severity in rabbits is reduced by IgG Fabs interfering with aggregation substance. Plos One. 5. PMID 20957231 DOI: 10.1371/Journal.Pone.0013194 |
0.335 |
|
| 2010 |
Schlievert PM, Nemeth KA, Davis CC, Peterson ML, Jones BE. Staphylococcus aureus exotoxins are present in vivo in tampons. Clinical and Vaccine Immunology : Cvi. 17: 722-7. PMID 20335433 DOI: 10.1128/Cvi.00483-09 |
0.407 |
|
| 2010 |
Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. The Journal of Allergy and Clinical Immunology. 125: 39-49. PMID 20109735 DOI: 10.1016/J.Jaci.2009.10.039 |
0.623 |
|
| 2010 |
Strandberg KL, Peterson ML, Lin YC, Pack MC, Chase DJ, Schlievert PM. Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus. Antimicrobial Agents and Chemotherapy. 54: 597-601. PMID 20008774 DOI: 10.1128/Aac.01151-09 |
0.547 |
|
| 2009 |
John CC, Niermann M, Sharon B, Peterson ML, Kranz DM, Schlievert PM. Staphylococcal toxic shock syndrome erythroderma is associated with superantigenicity and hypersensitivity. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1893-6. PMID 19911998 DOI: 10.1086/648441 |
0.35 |
|
| 2009 |
Strandberg KL, Peterson ML, Schaefers MM, Case LC, Pack MC, Chase DJ, Schlievert PM. Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1711-7. PMID 19863450 DOI: 10.1086/644614 |
0.737 |
|
| 2009 |
Lin YC, Schlievert PM, Anderson MJ, Fair CL, Schaefers MM, Muthyala R, Peterson ML. Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo. Plos One. 4: e7499. PMID 19838303 DOI: 10.1371/Journal.Pone.0007499 |
0.748 |
|
| 2009 |
Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, Southern PJ, Reilly CS, Peterson ML, Schultz-Darken N, Brunner KG, Nephew KR, Pambuccian S, Lifson JD, Carlis JV, Haase AT. Glycerol monolaurate prevents mucosal SIV transmission. Nature. 458: 1034-8. PMID 19262509 DOI: 10.1038/Nature07831 |
0.349 |
|
| 2009 |
Brosnahan AJ, Mantz MJ, Squier CA, Peterson ML, Schlievert PM. Cytolysins augment superantigen penetration of stratified mucosa. Journal of Immunology (Baltimore, Md. : 1950). 182: 2364-73. PMID 19201891 DOI: 10.4049/Jimmunol.0803283 |
0.432 |
|
| 2008 |
Brosnahan AJ, Schaefers MM, Amundson WH, Mantz MJ, Squier CA, Peterson ML, Schlievert PM. Novel toxic shock syndrome toxin-1 amino acids required for biological activity. Biochemistry. 47: 12995-3003. PMID 19012411 DOI: 10.1021/Bi801468W |
0.731 |
|
| 2008 |
Schlievert PM, Strandberg KL, Brosnahan AJ, Peterson ML, Pambuccian SE, Nephew KR, Brunner KG, Schultz-Darken NJ, Haase AT. Glycerol monolaurate does not alter rhesus macaque (Macaca mulatta) vaginal lactobacilli and is safe for chronic use. Antimicrobial Agents and Chemotherapy. 52: 4448-54. PMID 18838587 DOI: 10.1128/Aac.00989-08 |
0.367 |
|
| 2007 |
Schlievert PM, Case LC, Nemeth KA, Davis CC, Sun Y, Qin W, Wang F, Brosnahan AJ, Mleziva JA, Peterson ML, Jones BE. Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins. Biochemistry. 46: 14349-58. PMID 18020451 DOI: 10.1021/Bi701202W |
0.356 |
|
| 2007 |
Schlievert PM, Case LC, Strandberg KL, Tripp TJ, Lin YC, Peterson ML. Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005. Journal of Clinical Microbiology. 45: 2704-7. PMID 17537948 DOI: 10.1128/Jcm.02295-06 |
0.55 |
|
| 2007 |
Buonpane RA, Churchill HR, Moza B, Sundberg EJ, Peterson ML, Schlievert PM, Kranz DM. Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nature Medicine. 13: 725-9. PMID 17515896 DOI: 10.1038/Nm1584 |
0.355 |
|
| 2006 |
Peterson ML, Schlievert PM. Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells. Biochemistry. 45: 2387-97. PMID 16475828 DOI: 10.1021/Bi051992U |
0.4 |
|
| 2005 |
Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura fulminans due to Staphylococcus aureus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 941-7. PMID 15824983 DOI: 10.1086/428573 |
0.494 |
|
| 2005 |
Peterson ML, Ault K, Kremer MJ, Klingelhutz AJ, Davis CC, Squier CA, Schlievert PM. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infection and Immunity. 73: 2164-74. PMID 15784559 DOI: 10.1128/Iai.73.4.2164-2174.2005 |
0.441 |
|
| 2004 |
Schlievert PM, Tripp TJ, Peterson ML. Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. Journal of Clinical Microbiology. 42: 2875-6. PMID 15184497 DOI: 10.1128/Jcm.42.6.2875-2876.2004 |
0.33 |
|
| 2004 |
Ricci V, Peterson ML, Rotschafer JC, Wexler H, Piddock LJ. Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants. Antimicrobial Agents and Chemotherapy. 48: 1344-6. PMID 15047539 DOI: 10.1128/Aac.48.4.1344-1346.2004 |
0.315 |
|
| 2003 |
Peterson ML, Rotschafer JC, Piddock LJV. Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis Journal of Antimicrobial Chemotherapy. 52: 481-484. PMID 12917248 DOI: 10.1093/Jac/Dkg368 |
0.341 |
|
| 2002 |
Peterson ML, Hovde LB, Wright DH, Brown GH, Hoang AD, Rotschafer JC. Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model. Antimicrobial Agents and Chemotherapy. 46: 203-10. PMID 11751135 DOI: 10.1128/Aac.46.1.203-210.2002 |
0.348 |
|
| 2001 |
Ross GH, Wright DH, Hovde LB, Peterson ML, Rotschafer JC. Fluoroquinolone resistance in anaerobic bacteria following exposure to levofloxacin, trovafloxacin, and sparfloxacin in an in vitro pharmacodynamic model. Antimicrobial Agents and Chemotherapy. 45: 2136-40. PMID 11408238 DOI: 10.1128/Aac.45.7.2136-2140.2001 |
0.331 |
|
| 2000 |
Wright DH, Brown GH, Peterson ML, Rotschafer JC. Application of fluoroquinolone pharmacodynamics Journal of Antimicrobial Chemotherapy. 46: 669-683. PMID 11062185 DOI: 10.1093/Jac/46.5.669 |
0.327 |
|
| 1999 |
Peterson ML, Hovde LB, Wright DH, Hoang AD, Raddatz JK, Boysen PJ, Rotschafer JC. Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure. Antimicrobial Agents and Chemotherapy. 43: 2251-5. PMID 10471574 DOI: 10.1128/Aac.43.9.2251 |
0.37 |
|
| Show low-probability matches. |